Clinical Trial Update: Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer [NA]

View source ↗

Summary

The Canadian Cancer Trials Group reports an active, not-recruiting trial evaluating local ablative therapy for hormone-sensitive oligometastatic prostate cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Prostate Cancer Metastatic | NA | Status: ACTIVE_NOT_RECRUITING